PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'American Hospital, Department of Infectious Diseases and Clinical Microbiology, Istanbul, Turkey.\', \'Koç University, School of Medicine, Department of Infectious Diseases and Clinical Microbiology, Istanbul, Turkey.\', \'American Hospital, Department of Internal Medicine, Istanbul, Turkey.\', \'Koç University, School of Medicine, Department Anesthesiology & Intensive Care Unit, Istanbul, Turkey.\', \'American Hospital, Department of Radiology and Beykent University School of Medicine, Turkey.\', \'Koç University, College of Engineering, Department of Industrial Engineering, Istanbul, Turkey.\', \'American Hospital, Clinical Laboratory, Istanbul, Turkey.\', \'Koç University, School of Medicine, Department of Chest Diseases, Istanbul, Turkey.\', \'Koç University, School of Medicine, Department of Infectious Diseases and Clinical Microbiology, Istanbul, Turkey. Electronic address: oergonul@ku.edu.tr.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • S1201-9712(20)30580-410.1016/j.ijid.2020.07.036
?:hasPublicationType
?:journal
  • International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases
is ?:pmid of
?:pmid
?:pmid
  • 32726724
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
is ?:relation_isRelatedTo_publication of
?:title
  • Appropriate use of tocilizumab in COVID-19 infection.
?:type
?:year
  • 2020

Metadata

Anon_0  
expand all